US 11401256
Dihydroquinolinones for medical treatment
granted A61KA61K31/4375A61K31/4704
Quick answer
US patent 11401256 (Dihydroquinolinones for medical treatment) held by C4 THERAPEUTICS, INC. expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/4375, A61K31/4704, A61K47/55, A61P